Genomics and anterior segment dysgenesis: A review

Clinical and Experimental Ophthalmology

Volumn 42, Issue 1, 2014, Pages 13-24

  Ito, Yoko A ^a   Walter, Michael A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Axenfeld Rieger syndrome; Genome wide association; Linkage analysis; Peters anomaly; Phenotypic and genotypic heterogeneity

Indexed keywords

TRANSCRIPTION FACTOR FOXC1; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PITX2;

ANIRIDIA; ANTERIOR EYE SEGMENT; ANTERIOR SEGMENT DYSGENESIS; CONGENITAL GLAUCOMA; CORNEA DISEASE; DISEASE ASSOCIATION; EYE DISEASE; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LINKAGE ANALYSIS; MEGALOCORNEA; METHODOLOGY; PETERS ANOMALY; REVIEW; SCLEROCORNEA;

AXENFELD-RIEGER SYNDROME; GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; PETERS ANOMALY; PHENOTYPIC AND GENOTYPIC HETEROGENEITY;

ANTERIOR EYE SEGMENT; EYE ABNORMALITIES; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; GENOTYPE; HUMANS; PHENOTYPE;

EID: 84892558808     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12152     Document Type: Review

References (68)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267.
2. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 2006; 47: 4254-4261.
3. Strungaru MH, Dinu I, Walter MA. Genotype-phenotype correlations in Axenfeld-Rieger malformation and glaucoma patients with FOXC1 and PITX2 mutations. Invest Ophthalmol Vis Sci 2007; 48: 228-237.
4. Wilson ME. Congenital iris ectropion and a new classification for anterior segment dysgenesis. J Pediatr Ophthalmol Strabismus 1990; 27: 48-55.
5. Idrees F, Vaideanu D, Fraser SG, Sowden JC, Khaw PT. A review of anterior segment dysgeneses. Surv Ophthalmol 2006; 51: 213-231.
6. Waring GO, 3rd, Rodrigues MM, Laibson PR. Anterior chamber cleavage syndrome. A stepladder classification. Surv Ophthalmol 1975; 20: 3-27.
7. Alward WL. Axenfeld-Rieger syndrome in the age of molecular genetics. Am J Ophthalmol 2000; 130: 107-115.
8. McPherson R. From genome-wide association studies to functional genomics: new insights into cardiovascular disease. Can J Cardiol 2013; 29: 23-29.
9. Klein RJ, Zeiss C, Chew EY etal. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
10. Nischal KK. A new approach to the classification of neonatal corneal opacities. Curr Opin Ophthalmol 2012; 23: 344-354.
11. Sowden JC. Molecular and developmental mechanisms of anterior segment dysgenesis. Eye (Lond) 2007 Oct;21: 1310-1318.
12. Tumer Z, Bach-Holm D. Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations. Eur J Hum Genet 2009; 17: 1527-1539.
13. D'haene B, Meire F, Claerhout I etal. Expanding the spectrum of FOXC1 and PITX2 mutations and copy number changes in patients with anterior segment malformations. Invest Ophthalmol Vis Sci 2011; 52: 324-333.
14. Phillips JC, Del Bono EA, Haines JL etal. A second locus for Rieger syndrome maps to chromosome 13q14. Am J Hum Genet 1996; 59: 613-619.
15. Semina EV, Reiter R, Leysens NJ etal. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996; 14: 392-399.
16. Mears AJ, Jordan T, Mirzayans F etal. Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet 1998; 63: 1316-1328.
17. Mears AJ, Mirzayans F, Gould DB, Pearce WG, Walter MA. Autosomal dominant iridogoniodysgenesis anomaly maps to 6p25. Am J Hum Genet 1996; 59: 1321-1327.
18. Nishimura DY, Swiderski RE, Alward WL etal. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet 1998; 19: 140-147.
19. Harissi-Dagher M, Colby K. Anterior segment dysgenesis: Peters anomaly and sclerocornea. Int Ophthalmol Clin 2008; 48: 35-42.
20. Hanson IM, Fletcher JM, Jordan T etal. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat Genet 1994; 6: 168-173.
21. Doward W, Perveen R, Lloyd IC, Ridgway AE, Wilson L, Black GC. A mutation in the RIEG1 gene associated with Peters' anomaly. J Med Genet 1999; 36: 152-155.
22. Vincent A, Billingsley G, Priston M etal. Phenotypic heterogeneity of CYP1B1: mutations in a patient with Peters' anomaly. J Med Genet 2001; 38: 324-326.
23. Maillette de Buy Wenniger-Prick LJ, Hennekam RC. The Peters' plus syndrome: a review. Ann Genet 2002; 45: 97-103.
24. Zaidman GW, Flanagan JK, Furey CC. Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I. Am J Ophthalmol 2007; 144: 104-108.
25. Heinonen TY, Maki M. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1, 3-glucosyltransferase that modifies thrombospondin type 1 repeats. Ann Med 2009; 41: 2-10.
26. Lesnik Oberstein SA, Kriek M, White SJ etal. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Am J Hum Genet 2006; 79: 562-566.
27. Sarfarazi M, Akarsu AN, Hossain A etal. Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity. Genomics 1995; 30: 171-177.
28. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997; 6: 641-647.
29. Lee H, Khan R, O'Keefe M. Aniridia: current pathology and management. Acta Ophthalmol 2008; 86: 708-715.
30. Fantes JA, Bickmore WA, Fletcher JM, Ballesta F, Hanson IM, van Heyningen V. Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization. Am J Hum Genet 1992; 51: 1286-1294.
31. Ito YA, Footz TK, Berry FB etal. Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia. Invest Ophthalmol Vis Sci 2009; 50: 3573-3579.
32. Ciralsky J, Colby K. Congenital corneal opacities: a review with a focus on genetics. Semin Ophthalmol 2007; 22: 241-246.
33. Kirkness CM, McCartney A, Rice NS, Garner A, Steele AD. Congenital hereditary corneal oedema of Maumenee: its clinical features, management, and pathology. Br J Ophthalmol 1987; 71: 130-144.
34. Callaghan M, Hand CK, Kennedy SM, FitzSimon JS, Collum LM, Parfrey NA. Homozygosity mapping and linkage analysis demonstrate that autosomal recessive congenital hereditary endothelial dystrophy (CHED) and autosomal dominant CHED are genetically distinct. Br J Ophthalmol 1999; 83: 115-119.
35. Vithana EN, Morgan P, Sundaresan P etal. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet 2006; 38: 755-757.
36. Mataftsi A, Islam L, Kelberman D, Sowden JC, Nischal KK. Chromosome abnormalities and the genetics of congenital corneal opacification. Mol Vis 2011; 17: 1624-1640.
37. Webb TR, Matarin M, Gardner JC etal. X-linked megalocornea caused by mutations in CHRDL1 identifies an essential role for ventroptin in anterior segment development. Am J Hum Genet 2012; 90: 247-259.
38. Sheffield VC, Stone EM. Genomics and the eye. N Engl J Med 2011; 364: 1932-1942.
39. Pearce WG, Mielke BC, Kulak SC, Walter MA. Histopathology and molecular basis of iridogoniodysgenesis syndrome. Ophthalmic Genet 1999; 20: 83-88.
40. Tzoulaki I, White IM, Hanson IM. PAX6 mutations: genotype-phenotype correlations. BMC Genet 2005; 6: 27.
41. Shields MB. Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc 1983; 81: 736-784.
42. Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res 2008; 86: 543-561.
43. de Nadal E, Ammerer G, Posas F. Controlling gene expression in response to stress. Nat Rev Genet 2011; 12: 833-845.
44. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2: 165-174.
45. Smith RS, Zabaleta A, Kume T etal. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet 2000; 9: 1021-1032.
46. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17: 502-510.
47. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997; 278: 1580-1581.
48. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases. Am J Hum Genet 2001; 69: 124-137.
49. Reis LM, Tyler RC, Abdul-Rahman O etal. Mutation analysis of B3GALTL in Peters Plus syndrome. Am J Med Genet A 2008; 146A: 2603-2610.
50. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363: 166-176.
51. Visscher PM, Medland SE, Ferreira MA etal. Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings. Plos Genet 2006; 2: e41.
52. Thorleifsson G, Walters GB, Hewitt AW etal. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 2010; 42: 906-909.
53. Wiggs JL, Kang JH, Yaspan BL etal. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet 2011; 20: 4707-4713.
54. Kuehn MH, Wang K, Roos B etal. Chromosome 7q31 POAG locus: ocular expression of caveolins and lack of association with POAG in a US cohort. Mol Vis 2011; 8: 430-435.
55. Malik SR, Sing G, Gupta AK. Posterior embryotoxon. J All India Ophthalmol Soc 1969; 17: 115-116.
56. Liu Y, Allingham RR. Molecular genetics in glaucoma. Exp Eye Res 2011; 93: 331-339.
57. Hindorff LA, Sethupathy P, Junkins HA etal. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009; 106: 9362-9367.
58. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007; 8: 185-194.
59. Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol 2012; 30: 1095-1106.
60. Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010; 11: 843-854.
61. Teslovich TM, Musunuru K, Smith AV etal. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-713.
62. Sandhu MS, Waterworth DM, Debenham SL etal. LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008; 371: 483-491.
63. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011; 12: 56-68.
64. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc Natl Acad Sci U S A 2007; 104: 8685-8690.
65. Oti M, Snel B, Huynen MA, Brunner HG. Predicting disease genes using protein-protein interactions. J Med Genet 2006; 43: 691-698.
66. Acharya M, Huang L, Fleisch VC, Allison WT, Walter MA. A complex regulatory network of transcription factors critical for ocular development and disease. Hum Mol Genet 2011; 20: 1610-1624.
67. Berry FB, Lines MA, Oas JM etal. Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis. Hum Mol Genet 2006; 15: 905-919.
68. Manolio TA, Collins FS, Cox NJ etal. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.